In the JAKPOT derivation study, the absence of all three criteria ruled out JAK2 mutant erythrocytosis with a sensitivity of 95–100% and a false negative rate of 0.4%, but the score has not been externally validated. This evidence concerns the gene JAK2 and polycythemia.